DREN BIO
Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
DREN BIO
Industry:
Biotechnology Health Care Life Science
Founded:
2019-01-01
Address:
Foster City, California, United States
Country:
United States
Website Url:
http://www.drenbio.com
Total Employee:
1+
Status:
Active
Total Funding:
130.05 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Global Site Tag
Similar Organizations
hC Bioscience
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Q-State Biosciences
Q-State has developed world-leading technologies and proprietary approaches for probing rare and genetic CNS conditions.
Current Advisors List
Current Employees Featured
Founder
Investors List
HBM Partners
HBM Partners investment in Series B - Dren Bio
ArrowMark Partners
ArrowMark Partners investment in Series B - Dren Bio
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - Dren Bio
BVF Partners
BVF Partners investment in Series B - Dren Bio
Taiho Ventures
Taiho Ventures investment in Series B - Dren Bio
Aisling Capital
Aisling Capital investment in Series B - Dren Bio
Revelation Partners
Revelation Partners investment in Series B - Dren Bio
SR One
SR One investment in Series B - Dren Bio
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series B - Dren Bio
Mission BioCapital
Mission BioCapital investment in Series B - Dren Bio
Official Site Inspections
http://www.drenbio.com
- Host name: 215.246.12.198.host.secureserver.net
- IP address: 198.12.246.215
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Dren Bio"
Dren Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering …See details»
Dren Bio 2025 Company Profile: Valuation, Funding & Investors
Www.drenbio.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 384 Foster City Boulevard; Foster City, CA 94404; United StatesSee details»
DREN BIO, INC. Company Profile | Foster City, CA | Competitors ...
Find company research, competitor information, contact details & financial data for DREN BIO, INC. of Foster City, CA. Get the latest business insights from Dun & Bradstreet.See details»
Dren Bio, Inc. | LinkedIn
Dren Bio, Inc. | 2,594 followers on LinkedIn. Dren Bio is a Foster City, CA based biotechnology company, developing power protein-based technologies to deplete pathogenic cells and …See details»
Careers / Dren Bio
This is an opportunity to develop a substantially diverse skill set hands-on and to grow with the organization, and therefore we are seeking an individual with an energetic curiosity for …See details»
Dren Bio, Inc. Overview | SignalHire Company Profile
Dren Bio, Inc. is a private company that has been in the industry for 5 years. The company currently specializes in the Biotechnology, Health Care Services, Health Care Technology areasSee details»
Dren Bio Inc. - life-sciences-usa.com
Jan 1, 2019 Dren Bio is a privately held, clinical-stage biopharmaceutical company pioneering the discovery and development of novel first-in-class antibody therapeutics for the treatment of …See details»
Dren Bio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Www.drenbio.com. Startups | Holding Company | 2019 | California, United States | 10-50 | www.drenbio.com. Last update 07 Mar 2025. Overview. Pipeline. Deal. Translational …See details»
Dren Bio - Overview, News & Similar companies | ZoomInfo.com
Oct 16, 2023 Dren Bio contact info: Phone number: (415) 737-5277 Website: www.drenbio.com What does Dren Bio do? Dren Bio is a California based biotechnology company developing …See details»
Dren Bio - VentureRadar
"Dren Bio is a company developing powerful protein-engineering technologies for depletion of cells, protein aggregates and other disease-causing agents.See details»
Dren Bio Company Profile - Office Locations, Competitors ... - Craft
Dren Bio has 5 employees at their 1 location and $65.1 m in total funding,. See insights on Dren Bio including office locations, competitors, revenue, financials, executives, subsidiaries and …See details»
Dren Bio | Leukemia and Lymphoma Society
Dec 12, 2022 The Leukemia & Lymphoma Society is a 501(c)(3) organization, and all monetary donations are tax deductible to the fullest extent allowed by tax laws. Please check with your …See details»
Press Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell ...
3 days ago Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline Dren Bio deep B-cell depleter program has the potential to …See details»
Sanofi signs $1.9bn deal to buy Dren Bio autoimmune drug
3 days ago Sanofi says it has reached an agreement with Dren Bio that would see it take control of autoimmune disease treatment DR-0201, a bispecific antibody-based myeloid cell engager …See details»
Press Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell ...
Mar 20, 2006 For more information about Dren Bio and its current development pipeline, please visit Dren Bio’s website at www.drenbio.com. About Sanofi We are an innovative global …See details»
Sanofi outlays $1.9bn to purchase Dren Bio’s bispecific antibody
3 days ago Sanofi is increasing focus on innovative medicines while moving away from consumer health. Image credit: Shutterstock/Below the Sky. Sanofi is continuing its …See details»
Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for …
Jeff Macfarland, EVP, Finance | [email protected] . Sanofi forward-looking statements This press release contains forward-looking statements as defined in the Private Securities Litigation …See details»
Sanofi pens $1.9B deal for Dren Bio's bispecific
3 days ago The CD20-directed antibody, dubbed DR-0201, is a bispecific myeloid cell engager that Dren has been evaluating in a phase 1 trial for B-cell non-Hodgkin lymphoma.See details»
Dren Bio announces a $60M Series A financing | Business Wire
Oct 16, 2020 SAN CARLOS, Calif.--(BUSINESS WIRE)--Dren Bio, Inc., a company developing powerful protein-engineering technologies for depletion of cells, protein aggregates and other …See details»
Press Release: Sanofi to acquire Dren Bio’s bispecific
3 days ago Jeff Macfarland, EVP, Finance | [email protected] Sanofi forward-looking statements This press release contains forward-looking statements as defined in the Private Securities …See details»